GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: deuremidevir | JT001 | Mindavi® | VV-116 | VV116 | X6 hydrobromide [PMID: 34584244]
mindeudesivir is an approved drug (China NMPA (2023))
Compound class:
Synthetic organic
Comment: VV116 is an orally available, deuterated remdesivir analogue [6-7]. It is a tri-isobutyrate ester prodrug (formulated as the hydrobromide salt) that is converted to an active nucleoside triphosphate (116-NTP) that acts as a viral RNA-dependent RNA polymerase (RdRP) inhibitor. VV116 was developed for antiviral activity against SARS-CoV-2. We drew the chemical structure as represented in Xie et al. (2021) [6]. The chemical structure for VV116 was later matched to that for the INN mindeudesivir.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. China NMPA (2023) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12802 | mindeudesivir |
Synonyms ![]() |
| deuremidevir | JT001 | Mindavi® | VV-116 | VV116 | X6 hydrobromide [PMID: 34584244] |
Database Links ![]() |
|
| CAS Registry No. | 2647442-33-7 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL5314500 |
| GtoPdb PubChem SID | 464244134 |
| PubChem CID | 163358784 |
| Search Google for chemical match using the InChIKey | RVSSLHFYCSUAHY-QXMJNOOVSA-N |
| Search Google for chemicals with the same backbone | RVSSLHFYCSUAHY |
| Search PubMed clinical trials | mindeudesivir |
| Search PubMed titles | mindeudesivir |
| Search PubMed titles/abstracts | mindeudesivir |
| UniChem Compound Search for chemical match using the InChIKey | RVSSLHFYCSUAHY-QXMJNOOVSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | RVSSLHFYCSUAHY-QXMJNOOVSA-N |